A Booster Shot
Forbes India|February 26, 2021
Increased outlays for health, ₹35,000 crore for Covid-19 vaccines to help cope with immediate needs in light of the pandemic and help prepare for future eventualities
DIVYA J SHEKHAR

FINANCE MINISTER

Nirmala Sitharaman earmarked ₹35,000 crore toward Covid-19 vaccines in Union Budget 2021. “I am committed to provide further funds if required,” she said, adding that two more vaccines will be rolled out soon. Currently, India has granted emergency use authorisation for Covaxin, developed by Hyderabad-based Bharat Biotech, and Covishield, manufactured by the Serum Institute of India in Pune.

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM FORBES INDIAView All

EARNING HIS STRIPES

Following the success of The White Tiger, newcomer Adarsh Gourav finds himself in haloed territory of global award nominations

6 mins read
Forbes India
March 12, 2021

Forbes INDIA Leadership Awards 2020-21

In a year when business leaders were forced to overhaul their strategies from growth to survival mode, the Forbes India Leadership Awards honour those who successfully navigated the pandemic by innovating and leading from the front

10+ mins read
Forbes India
March 12, 2021

‘COVID-19 SPED UP EXISTING TRENDS IN THE MARKET'

Jean-Christophe Babin, CEO of the Bvlgari Group, on the impact of the pandemic on the luxury sector

5 mins read
Forbes India
March 12, 2021

How LTI Came Into Its Own

With Sanjay Jalona at the helm, the IT services company is winning against bigger rivals, stepping out of its larger parent’s shadow, and forging an identity for itself

9 mins read
Forbes India
March 12, 2021

Valuations of Consumer Companies in Slow Lane

Despite a bright business outlook, FMCG companies have not outperformed the markets

3 mins read
Forbes India
March 12, 2021

‘If You Don't Understand Technology or Data, You'll Become Obsolete'

Raja Rajamannar, CMO at Mastercard, talks about his book Quantum Marketing, and how marketers can stay relevant in the future

4 mins read
Forbes India
March 12, 2021

From Noun To Verb: Can Dunzo Do A Zoom?

It has raised close to ₹880 crore in six years, earned ₹27.5 crore and lost ₹338.4 crore. Critics may scoff, but Dunzo’s backers are not complaining, and co-founder Kabeer Biswas is chilled out

10 mins read
Forbes India
March 12, 2021

Bitcoin Gets A Shot In The Arm

Tesla’s $1.5 billion investment in cryptocurrency will encourage more corporates to gamble with it. Experts say India needs to join before it’s too late

10 mins read
Forbes India
March 12, 2021

Tech For Health: The Practo Way

With Covid-19 becoming a tipping point for business, the startup that helps people find and consult with doctors is doubling down on expanding and deepening its tech platforms

10 mins read
Forbes India
March 12, 2021

Can Koo Be King?

Forbes India delves deep into the new bird app and its content moderation policy to find out if the migration from Twitter will stick

10+ mins read
Forbes India
March 12, 2021